查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2046885

內視鏡市場－全球產業規模、佔有率、趨勢、機會、預測：按產業、產品、地區和競爭對手分類，2021-2031年

Endoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Industry Vertical, By Product By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球內視鏡市場預計將從 2025 年的 229.1 億美元大幅成長至 2031 年的 388.3 億美元，複合年成長率為 9.19%。

此市場區隔的核心在於醫療設備的研發，包括用於細胞內可視化和微創手術的具有光學和照明系統的剛性和軟性導管。慢性胃腸道疾病發病率的上升以及全球老年人口的不斷成長（需要頻繁進行診斷檢查）是推動這一成長的主要因素。美國癌症協會預測，到2025年，美國將新增約154,270例大腸癌病例，凸顯了臨床的緊迫性，因為這將需要大規模的內視鏡篩檢。

市場概覽
預測期 2027-2031
市場規模：2025年 229.1億美元
市場規模：2031年 388.3億美元
複合年成長率：2026-2031年 9.19%
成長最快的細分市場 靈活的
最大的市場 北美洲

儘管市場呈現強勁成長趨勢，但仍面臨諸多挑戰，包括複雜的再處理流程以及可重複使用內視鏡固有的感染風險。嚴格的消毒程序對於確保病人安全至關重要，但同時也導致高昂的營運成本和器械周轉率下降，從而降低臨床工作流程的效率。這些經濟和後勤方面的負擔對先進內視鏡技術的廣泛應用構成了重大挑戰，尤其是在醫療機構等高度重視成本的機構中。

市場促進因素

全球內視鏡市場正因影像技術的進步和人工智慧 (AI) 的整合而發生巨大變革，二者共同提升了診斷準確性和操作效率。將人工智慧整合到高清成像系統中，可實現病變的即時檢測，從而顯著改善臨床療效。市場對這些先進平台的需求體現在產業的強勁表現上。例如，Olympus Corporation公佈，截至2025年3月31日的會計年度，其內視鏡解決方案部門的銷售額成長了8%，這主要得益於其EVIS X1系統在北美市場的強勁銷售。這種技術發展動能也推動了市場的進一步擴張，其他主要廠商也呈現同樣的趨勢。例如，波士頓科學公司累計，其內視鏡部門在2025年前三個季度的淨銷售額為21.6億美元，證實了全球市場的強勁需求。

第二個關鍵促進因素是一次性內視鏡的日益普及，這主要是由於降低感染風險和最佳化手術流程的需求。一次性設備提供了一種無菌選擇，無需耗時的再處理流程，提高了患者安全性，並提供了操作柔軟性。這一領域的快速成長也體現在以金額為準。 Ambu A/S 在 2024/25 會計年度第三季中期報告中指出，其內視鏡解決方案業務實現了 15.9% 的內部成長，這主要得益於 aScope 產品線的廣泛應用。這一趨勢反映了醫療保健籌資策略的根本性轉變，即優先考慮感染控制和設備的即時可用性，而非傳統的可重複使用設備模式。

市場挑戰

全球內視鏡市場面臨許多挑戰，主要源自於為降低可重複使用裝置相關的感染風險而製定的嚴格且耗費資源的再處理流程。嚴格的滅菌要求，包括人工預清洗、洩漏測試和高級別消毒，顯著降低了設備的周轉率，並導致手術延誤。這種複雜的物流流程迫使醫療機構維持大量昂貴的內視鏡庫存，以控制檢查量，造成沉重的資金負擔。因此，這些財務和營運壓力直接阻礙了內視鏡設備的普及，尤其是在對成本高度敏感、效率至關重要的門診環境中。

此外，即使遵循相關指南，交叉感染的風險始終存在，這會削弱市場信心，並導致監管機構加強審查。軟式內視鏡複雜的內部通道容易累積生物膜，從而構成切實的病人安全風險，阻礙市場成長。這種風險對臨床實務影響顯著。例如，根據註冊圍手術全期護理師協會 (AORN) 2025 年的數據，門診手術中因內視鏡消毒不當導致的感染率約為每 1100 例手術 1 例。此類統計數據加劇了醫療保健系統對法律責任的擔憂，促使人們優先考慮降低風險而非採用新的內視鏡技術，最終減緩了整體市場擴張。

市場趨勢

微創醫療市場正因機器人輔助內視鏡系統的普及而發生根本性變革，這些系統能夠以前所未有的精確度進入複雜的解剖區域。與傳統的手動內視鏡不同，這些機器人平台具有卓越的穩定性和靈活性，這對於探索肺部周圍和深部胃腸道等複雜路徑至關重要。隨著醫院投資先進醫療設備以提升其診斷和治療能力，這項技術變革的特點是系統部署量迅速成長。近期行業統計數據清晰地展現了這一趨勢的強勁勢頭。直覺外科公司（Intuitive Surgical）在2025年10月報告稱，其「Ion」腔內系統的部署量已達954台，同比成長30%。

同時，在降低成本和提升病患便利性的雙重驅動下，隨著內視鏡手術從急診醫院轉移到門診手術中心（ASC），結構性轉變正在加速。門診手術中心為大量診斷檢測提供了極其高效且經濟的環境，促使保險公司和醫療服務提供者將常規病例從資源密集型醫院轉移出去。這種轉變正在改變服務提供模式，並推動門診領域收入的顯著成長。近期財務表現也印證了這一趨勢， 果凍 Partners報告稱，截至2025年11月，其在同一機構的收入成長了6.3%。這一成長軌跡顯然歸功於胃腸道和肌肉骨骼服務線的強勁表現。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球內視鏡市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按產業分類（能源電力、汽車交通運輸、製造業、航太國防、建築基礎設施、其他）
    • 產品類型（軟性、剛性、一次性）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球內視鏡市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • PENTAX Medical Corporation
  • Karl Storz SE & Co. KG
  • Hoya Corporation
  • Stryker Corporation
  • Smiths Medical Inc.
  • Richard Wolf GmbH
  • Arthrex Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23059

The Global Endoscope Market is predicted to expand significantly, rising from USD 22.91 Billion in 2025 to USD 38.83 Billion by 2031, demonstrating a 9.19% Compound Annual Growth Rate. This market segment is centered on the creation of medical devices, including both rigid and flexible tubes equipped with optical and illumination systems, designed for internal visualization and minimally invasive surgical interventions. This growth is strongly supported by the increasing occurrence of chronic gastrointestinal conditions and an expanding global elderly population that frequently requires diagnostic procedures. The urgent clinical need is highlighted by projections from the American Cancer Society, indicating an estimated 154,270 new cases of colorectal cancer in the U.S. in 2025, which will necessitate extensive endoscopic screening.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 22.91 Billion
Market Size 2031USD 38.83 Billion
CAGR 2026-20319.19%
Fastest Growing SegmentFlexible
Largest MarketNorth America

Despite this positive growth trajectory, the market faces a substantial obstacle in the form of complex reprocessing protocols and the inherent infection risks associated with reusable endoscopes. The stringent sterilization procedures essential for ensuring patient safety lead to considerable operational expenses and slow down equipment turnaround, thereby creating inefficiencies in clinical workflows. These financial and logistical demands present a major challenge to the widespread integration of advanced endoscopic technologies, especially in healthcare settings where cost is a significant concern.

Market Driver

The Global Endoscope Market is being profoundly transformed by advancements in visualization and the integration of artificial intelligence, which collectively boost diagnostic accuracy and operational efficiency. The incorporation of AI into high-definition imaging systems allows for real-time detection of lesions, leading to significantly better clinical outcomes. This demand for sophisticated platforms is evident in robust industry performance; for example, Olympus Corporation reported an 8% increase in its Endoscopic Solutions Division revenue for the fiscal year ending March 31, 2025, largely due to strong sales of the EVIS X1 system in North America. This technological momentum also contributes to broader market expansion, as reflected by other major players, with Boston Scientific's Endoscopy segment generating 2.16 billion dollars in net sales for the first nine months of 2025, underscoring consistent global demand.

A second key driver is the growing adoption of disposable and single-use endoscopes, propelled by the need to reduce infection risks and optimize procedural workflows. Single-use devices eliminate the expensive and time-consuming reprocessing steps, offering a sterile option that enhances patient safety and provides operational flexibility. The rapid expansion of this segment is quantifiable; Ambu A/S reported a 15.9% organic growth in its Endoscopy Solutions business in its Q3 2024/25 interim report, primarily driven by the increasing uptake of its aScope product line. This trend signifies a fundamental change in healthcare procurement strategies, prioritizing infection control and immediate device availability over traditional reusable capital equipment models.

Market Challenge

The Global Endoscope Market faces a significant obstacle due to the rigorous and resource-intensive nature of reprocessing protocols necessary to mitigate infection risks associated with reusable devices. Healthcare facilities experience substantial operational delays because stringent sterilization requirements-including manual pre-cleaning, leak testing, and high-level disinfection-dramatically slow down equipment turnaround times. This logistical complexity forces providers to maintain a larger, redundant stock of costly endoscopes to sustain procedure volumes, imposing a considerable capital burden. Consequently, these financial and workflow pressures directly hinder the rapid acquisition of additional endoscopic units, particularly in cost-sensitive ambulatory settings where efficiency is crucial.

Furthermore, the ongoing risk of cross-contamination, even when guidelines are followed, erodes market confidence and leads to increased regulatory oversight. The intricate internal channels of flexible endoscopes are susceptible to biofilm accumulation, creating tangible patient safety risks that impede market growth. This risk significantly impacts clinical operations; for instance, data from the Association of periOperative Registered Nurses (AORN) in 2025 indicated that infection rates linked to improperly sterilized endoscopes occurred in approximately one out of every 1,100 procedures within ambulatory surgical environments. Such statistics heighten liability concerns for healthcare systems, prompting them to prioritize risk reduction over the adoption of new endoscopic technologies, thereby slowing overall market expansion.

Market Trends

The market for minimally invasive care is being fundamentally reshaped by the expansion of robotic-assisted endoscopic systems, which enable access to complex anatomical regions with unparalleled precision. Unlike traditional manual scopes, these robotic platforms offer superior stability and articulation, vital for navigating intricate pathways such as those found in the peripheral lungs or deep gastrointestinal tract. This technological transformation is marked by a rapid increase in system installations as hospitals invest in advanced capital equipment to enhance their diagnostic and therapeutic capabilities. The momentum of this trend is clearly demonstrated by recent industry figures; Intuitive Surgical reported in October 2025 that the installed base of its Ion endoluminal system reached 954 units, representing a 30% increase from the previous year.

Simultaneously, there is an accelerating structural shift of endoscopic procedures from acute care hospitals towards Ambulatory Surgical Centers (ASCs), driven by the dual objectives of cost reduction and enhanced patient convenience. ASCs provide a highly efficient and more affordable setting for a large volume of diagnostic examinations, encouraging both payers and providers to move routine cases away from resource-intensive hospital environments. This operational migration is transforming service delivery models and fueling substantial revenue growth within the outpatient sector. This trend is corroborated by recent financial performance, with Surgery Partners reporting in November 2025 a 6.3% increase in same-facility revenues, a growth trajectory explicitly attributed to robust performance in gastrointestinal and musculoskeletal service lines.

Key Market Players

  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • PENTAX Medical Corporation
  • Karl Storz SE & Co. KG
  • Hoya Corporation
  • Stryker Corporation
  • Smiths Medical Inc.
  • Richard Wolf GmbH
  • Arthrex Inc.

Report Scope

In this report, the Global Endoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Endoscope Market, By Industry Vertical

  • Energy & Power
  • Automotive & Transportation
  • Manufacturing
  • Aerospace & Defense
  • Construction & Infrastructure
  • Others

Endoscope Market, By Product

  • Flexible
  • Rigid
  • Disposable

Endoscope Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Endoscope Market.

Available Customizations:

Global Endoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Endoscope Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Industry Vertical (Energy & Power, Automotive & Transportation, Manufacturing, Aerospace & Defense, Construction & Infrastructure, Others)
    • 5.2.2. By Product (Flexible, Rigid, Disposable)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Endoscope Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Industry Vertical
    • 6.2.2. By Product
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Endoscope Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Industry Vertical
        • 6.3.1.2.2. By Product
    • 6.3.2. Canada Endoscope Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Industry Vertical
        • 6.3.2.2.2. By Product
    • 6.3.3. Mexico Endoscope Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Industry Vertical
        • 6.3.3.2.2. By Product

7. Europe Endoscope Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Industry Vertical
    • 7.2.2. By Product
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Endoscope Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Industry Vertical
        • 7.3.1.2.2. By Product
    • 7.3.2. France Endoscope Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Industry Vertical
        • 7.3.2.2.2. By Product
    • 7.3.3. United Kingdom Endoscope Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Industry Vertical
        • 7.3.3.2.2. By Product
    • 7.3.4. Italy Endoscope Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Industry Vertical
        • 7.3.4.2.2. By Product
    • 7.3.5. Spain Endoscope Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Industry Vertical
        • 7.3.5.2.2. By Product

8. Asia Pacific Endoscope Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Industry Vertical
    • 8.2.2. By Product
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Endoscope Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Industry Vertical
        • 8.3.1.2.2. By Product
    • 8.3.2. India Endoscope Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Industry Vertical
        • 8.3.2.2.2. By Product
    • 8.3.3. Japan Endoscope Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Industry Vertical
        • 8.3.3.2.2. By Product
    • 8.3.4. South Korea Endoscope Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Industry Vertical
        • 8.3.4.2.2. By Product
    • 8.3.5. Australia Endoscope Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Industry Vertical
        • 8.3.5.2.2. By Product

9. Middle East & Africa Endoscope Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Industry Vertical
    • 9.2.2. By Product
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Endoscope Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Industry Vertical
        • 9.3.1.2.2. By Product
    • 9.3.2. UAE Endoscope Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Industry Vertical
        • 9.3.2.2.2. By Product
    • 9.3.3. South Africa Endoscope Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Industry Vertical
        • 9.3.3.2.2. By Product

10. South America Endoscope Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Industry Vertical
    • 10.2.2. By Product
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Endoscope Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Industry Vertical
        • 10.3.1.2.2. By Product
    • 10.3.2. Colombia Endoscope Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Industry Vertical
        • 10.3.2.2.2. By Product
    • 10.3.3. Argentina Endoscope Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Industry Vertical
        • 10.3.3.2.2. By Product

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Endoscope Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Olympus Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Fujifilm Holdings Corporation
  • 15.3. PENTAX Medical Corporation
  • 15.4. Karl Storz SE & Co. KG
  • 15.5. Hoya Corporation
  • 15.6. Stryker Corporation
  • 15.7. Smiths Medical Inc.
  • 15.8. Richard Wolf GmbH
  • 15.9. Arthrex Inc.

16. Strategic Recommendations

17. About Us & Disclaimer